P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
MONDAY, July 10, 2023 (HealthDay News) — For patients with coronary artery disease (CAD), P2Y12 inhibitor monotherapy is associated with a lower risk for cardiovascular death, myocardial infarction, and stroke compared with aspirin monotherapy, accor…
Learn MoreLow-Dose Aspirin Could Raise Anemia Risks in Older Adults
TUESDAY, June 20, 2023 (HealthDay News) — Taking daily low-dose aspirin increases the risk of anemia in the elderly, a new clinical trial suggests.Not only does it raise anemia risk by more than 20% in people 70 or older, it is also associated with a…
Learn MoreIncrease in Incident Anemia Seen With Low-Dose Aspirin in Older Adults
TUESDAY, June 20, 2023 (HealthDay News) — For older adults, low-dose aspirin is associated with increased incident anemia and a decrease in ferritin when compared with placebo, according to a study published online June 20 in the Annals of Internal M…
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn MoreGenetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
TUESDAY, March 7, 2023 (HealthDay News) — Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, according to a study published online Feb. 24 in JAMA Network Open.Lauren M. Hurw…
Learn MoreAspirin Discontinuation Noninferior for Preventing Preeclampsia
THURSDAY, March 2, 2023 (HealthDay News) — For pregnant individuals at high risk for preeclampsia with a normal soluble fms-like tyrosine kinase-1 to placental growth factor (sFlt-1:PlGF) ratio, aspirin discontinuation between 24 and 28 weeks of gest…
Learn MoreSe puede tomar aspirina tras una factura para ayudar a evitar los coágulos sanguíneos
JUEVES, 19 de enero de 2023 (HealthDay News) — Cuando las personas se someten a una cirugía por una fractura de brazo o de pierna, con frecuencia les inyectan anticoagulantes recetados para reducir su riesgo de desarrollar unos coágulos sanguíneos po…
Learn MoreAspirin Noninferior to Low-Molecular-Weight Heparin After Fracture
FRIDAY, Jan. 20, 2023 (HealthDay News) — For patients with orthopedic trauma, thromboprophylaxis with aspirin is noninferior to low-molecular-weight heparin for preventing death, according to a study published in the Jan. 19 issue of the New England …
Learn MoreAspirin Noninferior to Low-Molecular-Weight Heparin After Fracture
FRIDAY, Jan. 20, 2023 (HealthDay News) — For patients with orthopedic trauma, thromboprophylaxis with aspirin is noninferior to low-molecular-weight heparin for preventing death, according to a study published in the Jan. 19 issue of the New England …
Learn More